Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
163 participants
OBSERVATIONAL
2020-04-10
2020-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Advanced Endoscopy During COVID-19
NCT04385147
Global State of Digestive Endoscopy Training Survey
NCT02735655
Endoscopic Interventions in Patients With COVID-19
NCT04423003
COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit
NCT04374123
A Multicentric Validation Study on the Accuracy of Artificial Intelligence Assisted System in Clinical Application of Digestive Endoscopy
NCT04232462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Participating center data:
* Participant name (surname, first name): (optional)
* Participant email: (optional)
* Country: ……..
* Working days (before COVID-19): ……..
* Types of procedure performed /day (before COVID-19): …….
* Number of endoscopists /day (before COVID-19): …….
* Number of nursing staff /day (before COVID-19): …….
* Number of administrative staff /day (before COVID-19): …….
* Number of patients undergoing endoscopy/ day (before COVID-19): …….
* Availability of negative pressure rooms (before COVID-19): …….
* Number of endoscopy referrals/ day (before COVID-19): ……..
2. Response to COVID-19:
* Working days (after COVID-19): ……..
* Types of procedure performed /day (after COVID-19): ……..
* Number of endoscopists /day (after COVID-19): ……..
* Number of nursing staff /day (after COVID-19): ……..
* Number of administrative staff /day (after COVID-19): ……..
* Do you consider teams (MD, RN, tech, anesthesia) that remain together for the entire day so as to compartmentalize and minimize personnel exposure?
* Number of patients undergoing endoscopy/ day (after COVID-19): ……..
* Number of endoscopy referrals/ day (after COVID-19): ……..
* Availability of negative pressure rooms or use portable industrial-grade high-efficiency particulate air (HEPA) filters as a reasonable alternative: ……..
* Which recommendations do you follow? WEO, AGA, BSG, APSDE, other
* Applying triage for patients: e.g. FTOCC (APSDE); dose this include any tests
* Do you use any of this for triage of patients: i) a telephone consultation with the referring provider or (ii) a telehealth visit with the patient or (iii) a multidisciplinary team approach or (virtual) disease/tumor board to facilitate decision-making for complicated patients.
* Prioritization:
Which classification do you use for endoscopic procedures?
1. urgent, semi-urgent and elective during COVID-19 outbreak
2. Time sensitive procedure:
* Time-sensitive procedures defined as procedures that if deferred may negatively impact patient-important outcomes. The decision to defer a procedure should be made on a case-by-case basis:
* Time-Sensitive\* (within 24 hours-8 weeks):
1. Threat to the patient's life or Permanent dysfunction of an organ e.g. diagnosis and treatment of GI bleeding or cholangitis
2. Risk of metastasis or progression of stage of disease e.g. e.g. work up of symptoms suggestive of cancer
3. Risk of rapidly worsening progression of disease or severity of symptoms e.g. management decisions, such as treatment for IBD
* Non-Time Sensitive: No short-term impact on patient-important outcomes e.g. screening or surveillance colonoscopy, follow up colonoscopy for +FIT
* What are the most common clinical presentations? (please choose all that apply): Upper GI bleeding, lower GI bleeding, cholangitis, suspected cancer, foreign body, relive of GI obstruction, gastrostomy, other
3. Endoscopy and use of PPE:
* Did you receive appropriate education and training on infection control measures, including hand hygiene.
* Did you receive adequate training on gowning and removal of PPE?
* Do you practice Standard hand hygiene procedures before and after each case?
* What type of personal protective equipment (PPE) do you usually use for doing an endoscopic procedure nowadays? (choose all that apply)
Surgical mask N95 mask Isolation gown with water resistance Head cover Eye protection Face shield N95 protection in combination with face shield or surgical mask Other (please specify): ……..
* Do you extend (over 8 hours) use of N95 masks?
* Do you re-use of N95 masks?
* Do you extend use (over 8 hours) any other equipment? : …..
* Do you re use any other equipment? …..
* If yes, please specify: …… If yes please specify: …..
* Do you use of double gloves? ……
* What PPE do you use for the following cases (choose all that apply)?
1. Suspected cases of SARS-CoV-2 infection:
Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify
2. Probable cases of SARS-CoV-2 infection:
Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify
3. confirmed cases of SARS-CoV-2 infection: Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify
4. Post endoscopy:
* Do you motion in your report the status of the patients (suspected, probable, confirmed case of SARS-CoV-2 infection?
* Do you use standard endoscopic decontamination or anything extra?
* Do you give time for sterilizing endoscopy room after each suspected or confirmed case of SARS-CoV-2 infection? How long?
* Do you call back your patients 2 weeks after procedure to ask them about symptoms/ diagnosis of SARS-CoV-2 infection?
* Did you report any endoscopy related SARS-CoV-2 infection in your center (anytime for HCWs \& up to two weeks after procedures for patients)?
* Are you preparing a management plan for the waiting list after the current phase of the pandemic?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Practicing gastroenterologists
Practicing physicians performing gastrointestinal endoscpy
Practice details
Physicians will report details of their endoscopy practice through answering the questions of the questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Practice details
Physicians will report details of their endoscopy practice through answering the questions of the questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Alboraie
Lecturer of medicine and gastroenterology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kings County Hospital Center, Brooklyn, NY, USA
Albertson, New York, United States
Faculty of Medicine, Zagazig University
Zagazig, Sharqia Province, Egypt
Al-Azhar Univerisity
Cairo, , Egypt
Ahvaz Imam hospital
Ahvāz, , Iran
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011 Apr 9;377(9773):1264-75. doi: 10.1016/S0140-6736(10)61459-6. Epub 2011 Mar 22.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Siddique SM, Falck-Ytter Y, El-Serag HB; AGA Institute. Electronic address: [email protected]. AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic. Gastroenterology. 2020 Aug;159(2):739-758.e4. doi: 10.1053/j.gastro.2020.03.072. Epub 2020 Apr 1. No abstract available.
Chiu PWY, Ng SC, Inoue H, Reddy DN, Ling Hu E, Cho JY, Ho LK, Hewett DG, Chiu HM, Rerknimitr R, Wang HP, Ho SH, Seo DW, Goh KL, Tajiri H, Kitano S, Chan FKL. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Gut. 2020 Jun;69(6):991-996. doi: 10.1136/gutjnl-2020-321185. Epub 2020 Apr 2.
Related Links
Access external resources that provide additional context or updates about the study.
WHO: Coronavirus Disease 2019 (COVID-19): Situation Report--51. WHO website. Published March 11, 2020. Accessed April 6, 2020.
WEO COVID-19 Response Taskforce. WEO Advice to Endoscopists. accessed April 7, 2020.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WES-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.